Zoetis Gets Conditional License From USDA
Zoetis Gets Conditional License From USDA for Bird Flu Vaccine
Zoetis said the U.S. Department of Agriculture's Center for Veterinary Biologics issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens, the company said.
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
BofA lowered the firm’s price target on Zoetis (ZTS) to $200 from $205 and keeps a Buy rating on the shares. Zoetis reported “solid” Q4 results ...
Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...
Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...
Barclays raised the firm’s price target on Zoetis (ZTS) to $244 from $242 and keeps an Overweight rating on the shares. The company’s 2025 ...
Q4 2024 Earnings Call Feb 13, 2025, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.
Zoetis posted Q4 earnings above estimates with strong organic growth. 2025 guidance signals lower-than-expected revenue and ...
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback